CELLINK
-
Swedish bioprinting firm CELLINK has announced it has formed an alliance with Swiss chemicals and biotech company Lonza. Through the agreement, the partners will combine CELLINK’s 3D bioprinting systems and…
-
Bioprinting company CELLINK has announced it has entered into an agreement with life science company cytena GmbH to acquire all of the company’s shares for €30.25 million (roughly $33.87 million).…
-
The very niche subsegment of 3D bioprinting in space has had a development that we’re excited to report: Swedish bioprinting company CELLINK recently announced that it sent 3D bioprinted stem…
-
Vladimir Mironov, Chief Scientific Officer at 3D Bioprinting Solutions (3D Bio) and Leading Scientist at Regenerative Medicine Institute of the Moscow Sechenov Medical University, Russia will be the main instructors…
-
Bioprinting company CELLINK is continually striving to advance the possibilities of additive manufacturing in the medical, and specifically bioprinting, field. To highlight its efforts, the company recently hosted a Collaborative Partnership Conference…
-
After INKing a number of high profile collaboration deals, CELLINK is now launching yet another a partnership with Volumetric, a Texas-based startup. The two companies will combine their expertise to…
-
Swedish bioprinting company CELLINK has received SEK 10 million in funding (roughly €965,775) from the EU to pursue a bioink development project in collaboration with the Academisch Centrum Tandheelkunde Amsterdam…
-
Swedish bioprinting company CELLINK has entered into a partnership with organ and tissue engineering company Prellis Biologics, Inc. with the goal of commercializing high-resolution holographic bioprinting technology for micro-scale printing.…
-
Swedish 3D bioprinter manufacturer CELLINK is launching a brand new bioink containing BIOLAMININ, that will enable scientists to combine the unique properties of the laminin protein with culturing cells in…
-
CELLINK, the Swedish startup that created one of the first universal bioinks and manufacturers cost effective bioprinters, is working on a EU co-funded project called TumorPrint. The project aims to develop…
